Related Experiment Video
Updated: Jan 2, 2026

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts
Published on: April 13, 2022
Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell
Anke Werner1,2, Daniel Pieh2, Hakim Echchannaoui1
1Third Department of Medicine (Hematology, Oncology, and Pneumology), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Abstract:
Interfering with tumor metabolism by specifically restricting the availability of extracellular nutrients is a rapidly emerging field of cancer research. A variety of tumor entities depend on the uptake of the amino acid arginine since they have lost the ability to synthesize it endogenously, that is they do not express the rate limiting enzyme for arginine synthesis, argininosuccinate synthase (ASS). Arginine transport through the plasma membrane of mammalian cells is mediated by eight different transporters that belong to two solute carrier (SLC) families. In the present study we found that the proliferation of primary as well as immortalized chronic lymphocytic leukemia (CLL) cells depends on the availability of extracellular arginine and that primary CLL cells do not express ASS and are therefore arginine-auxotrophic. The cationic amino acid transporter-1 (CAT-1) was the only arginine importer expressed in CLL cells. Lentiviral-mediated downregulation of the CAT-1 transporter in HG3 CLL cells significantly reduced arginine uptake, abolished cell proliferation and impaired cell viability. In a murine CLL xenograft model, tumor growth was significantly suppressed upon induced downregulation of CAT-1 in the CLL cells. Our results suggest that inhibition of CAT-1 is a promising new therapeutic approach for CLL.
Insights
Chronic lymphocytic leukemia (CLL) cells require extracellular arginine for growth and lack its endogenous synthesis. Inhibiting the arginine transporter CAT-1 halts proliferation and tumor growth, offering a potential new therapy for CLL.
Area of Science:
- Oncology
- Cancer Metabolism
- Amino Acid Transport
Background:
- Tumor cells often rely on external nutrients, including arginine, due to impaired endogenous synthesis.
- Chronic lymphocytic leukemia (CLL) cells are identified as arginine-auxotrophic, lacking argininosuccinate synthase (ASS).
- Arginine uptake in mammalian cells is facilitated by solute carrier (SLC) family transporters.
Purpose of the Study:
- To investigate the dependence of chronic lymphocytic leukemia (CLL) cells on extracellular arginine.
- To identify the specific arginine transporter(s) utilized by CLL cells.
- To evaluate the therapeutic potential of targeting arginine transport in CLL.
Main Methods:
- Assessed arginine dependence and ASS expression in primary and immortalized CLL cells.
- Utilized lentiviral-mediated gene downregulation to inhibit the cationic amino acid transporter-1 (CAT-1) in HG3 CLL cells.
- Evaluated the impact of CAT-1 inhibition on arginine uptake, proliferation, viability, and tumor growth in a murine xenograft model.
Main Results:
- CLL cells were confirmed to be arginine-auxotrophic, expressing only CAT-1 for arginine import.
- Downregulation of CAT-1 significantly reduced arginine uptake, proliferation, and viability of HG3 CLL cells.
- In vivo, CAT-1 inhibition in CLL cells led to significant suppression of tumor growth in a murine model.
Conclusions:
- Targeting extracellular arginine availability is a viable strategy for cancer therapy.
- CAT-1 is the primary arginine importer in CLL cells and a critical dependency.
- Inhibition of CAT-1 presents a promising therapeutic approach for treating chronic lymphocytic leukemia.
More Related Videos
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
13:16Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles
Published on: December 31, 2019
Related Concept Videos
ABC Transporters: Exporter
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Amino Acid Biosynthetic Pathways
Ligand-Gated Ion Channel Receptor: Gating Mechanism